Catalyst Wire Dossier Catalyst Wire Dossier

GamCovidVac

vector vaccine · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GamCovidVac, covering 2023-10-05 to 2023-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers [Phase 3]

See pricing